2) NT-proBNP
N末端脑利钠肽前体
1.
The dynamic change of NT-proBNP in patients with multiple injury at the early stage after trauma and its evaluation value of injury severity;
多发伤患者早期N末端脑利钠肽前体动态变化及其伤情评估价值
3) Nt-proBNP
脑利钠肽N端前体肽
1.
Objective To explore clinical significance of differential diagnosis of plasma Nt-proBNP concentration change between patients with cardiac dyspea and airway inflammatory disease.
目的探讨脑利钠肽N端前体肽(Nt-proBNP)在呼吸困难患者中的水平变化及其临床意义。
2.
To Study Clinical Significance of Differential Diagnosis of Plasma Nt-proBNP Concentration Change between Patients with Cardiac Dyspea and Airway Inflammatory Disease;
目的:探讨脑利钠肽N端前体肽(Nt-proBNP)在呼吸困难患者血浆中的水平变化及其临床意义。
6) NT-proBNP
N-端脑钠素前体
1.
Clinical investigation of Nt-proBNP predicting recurrence after cardioversion of lone atrial fibrillation
N-端脑钠素前体预测孤立性心房颤动复律后复发的临床研究
2.
Objective:The present study evaluated the consequences by Carvedilol treatment on chronic heart failure(CHF) and changes of plasma level of N-terminal pro-brain natriuretic peptide (NT-proBNP).
目的:探讨卡维地洛治疗慢性心力衰竭短期疗效及对血浆N-端脑钠素前体(Nt-proBNP)的影响。
补充资料:[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式:C16H16ClN3O3S
分子量:365.5
CAS号:26807-65-8
性质:暂无
制备方法:暂无
用途:用于轻、中度原发性高血压。
分子量:365.5
CAS号:26807-65-8
性质:暂无
制备方法:暂无
用途:用于轻、中度原发性高血压。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条